May 9 is International Clinical Trials Day

Thanks HealthResearchBoard National Clinical Trials Office for featuring lung cancer as a priority area

Join us! On how to build & sustain a clinical trials program, focusing on lung cancer

Beaumont RCSI Cancer Centre NCCP CancerTrialsIreland 🌈 IASLC

Review article “Cellular Senescence in Lung Cancer” in Ageing Research Review
Gabriele De Rubis Shankar Raj Devkota Samir Mehndiratta Gaurav Gupta Sachin Kumar Singh Nisha Panth Kamal Dua Hansbro Research UTS Science UTS Graduate School of Health Centenary Institute
IASLC Prevent Cancer Foundation
sciencedirect.com/science/articl…

@ESMO and Dr Tony Mok gave a wonderful platform to learn from great mentors like Dr Rafal Dziadziuszko, Dr Natasha Leighl and Dr Yi-Long Wu. It was wonderful to meet future thoracic oncologists and share ideas. #IASLC #LungCancer #HongKong #ESMO #Mentorship #ThoracicOncology

In company of Dr Yi-Long Wu, Dr Thanyanan Baisamut (Reungwetwattana) & Dr Tony Mok. A much needed asian perspective on thoracic oncology. #NSCLC #LungCancer #Esmo #IASLC #AdvancedCourse #HongKong

It’s a joy to listen to Karen Kelly discussing, at Mayo Clinic Comprehensive Cancer Center grand rounds, advancements in #lungcancer treatment and the ongoing evolution of the field for the benefit of our patients
#CancerResearch
IASLC Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation

Pooled 5-year outcomes of Pembrolizumab and Chemotherapy for PDL1<1% metastatic NSCLC in the Journal of Thoracic Oncology - Jarushka Naidoo
JTO & JTO CRR IASLC OncoAlert Shirish Gadgeel
oncodaily.com/54312.html

#ASCO #Cancer #Chemotherapy #ThoracicOncology #OncoDaily #Oncology

#IASLC 2024 Asia Conference on Lung Cancer #ACLC24 will be held in 🇭🇰Hong Kong, China, from October 17-19, 2024. Don't hesitate to submit your abstracts!

It's your last chance to get involved with our patient-outreach survey!

Help #LungCancer patients with their understanding of biomarker treatments

Don't miss this opportunity to make a difference
Sign up NOW
👉ow.ly/SaTF50Rsjoh

with LUNGevity Foundation, Lung Cancer Europe & IASLC

Thank you, IDEOLogy and our friends, colleagues, and our co-chairs Tina Cascone and Stephen Liu for your extraordinary work and organization. Thank you for this amazing conference. God bless you all. IDEOlogy Health Stephen V Liu, MD The Oncology Institute IASLC FLASCO Dr. Luis E. Raez

Official pics of the All Ireland Lung Cancer Conference 2024 are out #AILCC24 !

Thanks to faculty, attendees & the organizing committee for an unforgettable event

Till 2026

Beaumont RCSI Cancer Centre Trinity St James's Cancer Institute Cancer Research @UCC Ollscoil na Gaillimhe | University of Galway Cancer Trials Mater University Of Limerick St Vincent's University Hospital (SVUH) IASLC ESMO - Eur. Oncology

We are grateful for the esteemed endorsement from IASLC for #TexasLung24 . The attendees enjoyed invaluable insights from Dr. Karen Kelly, CEO of IASLC. Thank you for all you do. #LungHealth #LCSM

Beaumont RCSI Cancer Centre Trinity St James's Cancer Institute Cancer Research @UCC Ollscoil na Gaillimhe | University of Galway Cancer Trials Mater University Of Limerick St Vincent's University Hospital (SVUH) IASLC ESMO - Eur. Oncology Patrick Forde CatríonaMDowling PhD Gerry Hanna Gerard Walls Lizza Hendriks Curioni_Oncology_MD Dr. Julie Brahmer Jordi Remon Sanjay Popat Seamus Cotter More action shots

Join us June 25, for a live virtual expert-led cancer #immunotherapy program, ACI: A Focus on Lung Cancers. This program features a discussion on IO and biomarker-driven lung cancer. Register now: ow.ly/qOoK50RstN7
#NSCLC IASLC #LCSM Narjust Florez, MD, FASCO Ticiana Batista (Leal)

Stay tuned for a great episode about adenosquamous lung cancer with Drs. Sholl and Dr Riyaz Shah in Lung Cancer Consider the official IASLC podcast.

Amazing conversation.

Pooled 5-yr outcomes of Pembro+Chemo for PDL1<1% metastatic NSCLC JTO & JTO CRR:

- 442pts (KN189, KN407 &China/Japan extensions)
- mOS 0.64, mPFS HR 0.66, 5yr OS 12.5 v 9.3% favors chemo-IO
- g3+ TRAEs 59.1% chemo-IO

IASLC OncoAlert Shirish Gadgeel
#LCSM
jto.org/article/S1556-…

A timely discussion with Narjust Florez, MD, FASCO about the ALINA trial - Ben Solomon
@iaslc

#NSCLC #LungCancer #OncoDaily #Oncology #ClinicalTrials

oncodaily.com/54341.html

Our work on long-term outcomes to PD-1 monotherapy by increasing PD-L1 levels in NSCLC is out in JTO and JTO CRR - Biagio Ricciuti, MD PhD
Dana-Farber JTO & JTO CRR IASLC

#Cancer #Cancer Research #ClinicalTrial #ThoracicOncology #NSCLC #OncoDaily #Oncology

oncodaily.com/54771.html

Did you know, in 2012, the #IASLC applied to become a certified provider of continuing medical education (CME) by the Accreditation Council of Continuing Medical Education (ACCME). Ever since, we have been the CME provider for our meetings/educational offering! #IASLC 50 #LCSM

KRAS mutations are common in #lungcancer , & while there are multiple approved/active KRAS inhibitors, they are specifically for the G12C mutation. Stephen V Liu, MD discusses KRAS mutant #NSCLC w/focus on non-G12C mutations w/Dr. Veluswamy & Mariana Brandao: bit.ly/24KRASG12C